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Ror2 receptor tyrosine kinase has been shown to act as a receptor for Wnt5a to mediate β‐catenin‐independent non‐canonical Wnt signaling.[1](#cas12871-bib-0001){ref-type="ref"}, [2](#cas12871-bib-0002){ref-type="ref"}, [3](#cas12871-bib-0003){ref-type="ref"} Ror2 is expressed highly in various types of cancer cells,[4](#cas12871-bib-0004){ref-type="ref"}, [5](#cas12871-bib-0005){ref-type="ref"} and both Ror2 and Wnt5a are also expressed at high levels in several cancer cells, including osteosarcomas and melanomas, resulting in constitutive activation of Wnt5a‐Ror2 signaling in a cell‐autonomous manner.[6](#cas12871-bib-0006){ref-type="ref"}, [7](#cas12871-bib-0007){ref-type="ref"}, [8](#cas12871-bib-0008){ref-type="ref"} In fact, it has been shown that constitutively activated Wnt5a‐Ror2 signaling results in the activation of Src‐family protein tyrosine kinases and of c‐Jun N‐terminal kinase, leading to expression of MMP‐13 and formation of invadopodia, which confer invasive properties on osteosarcoma cells.[6](#cas12871-bib-0006){ref-type="ref"}, [9](#cas12871-bib-0009){ref-type="ref"} It has been well appreciated that cancer progression is mediated not only by alterations in the cancer cells, but also by the cancer‐associated stroma.[10](#cas12871-bib-0010){ref-type="ref"} Among several cell types, constituting the cancer‐associated stroma, much attention has been paid to the role of bone marrow‐derived mesenchymal stem cells (MSCs), which show a strong tropism for cancer cells, in cancer progression.[11](#cas12871-bib-0011){ref-type="ref"}, [12](#cas12871-bib-0012){ref-type="ref"}, [13](#cas12871-bib-0013){ref-type="ref"} However, little is known about the role of Wnt5a‐Ror2 signaling in MSCs in regulating cancer cell behaviors.

Bone marrow‐derived MSCs represent a phenotypically heterogeneous population of cells, yet characterized by expression of cell surface molecules, including CD73, CD90, and CD105, their ability to proliferate *ex vivo*, and by their potential to differentiate into multilineage mesenchymal cells, including cancer‐associated fibroblasts (CAFs).[11](#cas12871-bib-0011){ref-type="ref"}, [12](#cas12871-bib-0012){ref-type="ref"}, [13](#cas12871-bib-0013){ref-type="ref"}, [14](#cas12871-bib-0014){ref-type="ref"}, [15](#cas12871-bib-0015){ref-type="ref"} The relationship between MSCs and cancer cells can be bidirectional. Mesenchymal stem cells express and produce a number of growth factors, cytokines, and chemokines, and also express receptors for various growth factors and inflammatory cytokines under different microenvironments or conditions.[11](#cas12871-bib-0011){ref-type="ref"}, [12](#cas12871-bib-0012){ref-type="ref"}, [13](#cas12871-bib-0013){ref-type="ref"} Thus, the effects of MSCs on cancer cells might be dependent on types or characteristics of the cancer cells.

In this study, we have examined the role of Wnt5a‐Ror2 signaling in bone marrow‐derived MSCs in regulating proliferation of an undifferentiated gastric cancer cell line, MKN45. It was found that MSCs express *Wnt5a* and *Ror2* at relatively high levels, whereas MKN45 cells express *Wnt5a* and *Ror2* at marginal levels, if at all.[16](#cas12871-bib-0016){ref-type="ref"} Coculture of MKN45 cells with MSCs either directly or indirectly promotes proliferation of MKN45 cells. We show that Wnt5a‐Ror2 signaling in MSCs plays a role in expression of chemokine (C‐X‐C motif) ligand (CXCL)16 in MSCs and its secretion from MSCs. Interestingly, MKN45 cells express a receptor for CXCL16, CXCR6, thereby they proliferate in response to CXCL16 produced by MSCs. Our findings show for the first time that Wnt5a‐Ror2 signaling in MSCs promotes proliferation of MKN45 cells by activating CXCR6 signaling in MKN45 cells through the binding of CXCL16, produced by MSCs. Therefore, it can be envisaged that Wnt5a‐Ror2 signaling in MSCs and/or the CXCL16--CXCR6 axis might be effective therapeutic targets for some types of gastric cancer cells.

Materials and Methods {#cas12871-sec-0002}
=====================

Cell culture {#cas12871-sec-0003}
------------

MKN45‐Luc cells, which express luciferase stably, were obtained from JCRB cell bank (Osaka, Japan) and maintained in RPMI‐1640 medium (Nacalai Tesque, Tokyo, Japan) containing 10% FBS. Mesenchymal stem cells, primary human MSCs derived from bone marrow, were purchased from Lonza (Basel, Switzerland). The cells were maintained in MSCGM (Lonza) and used by passage 5. These cells were incubated at 37°C with 5% CO~2~ and 90% humidity. In some experiments, MKN45‐Luc cells were treated with soluble recombinant human CXCL16 (PeproTech, Oak Park, CA, USA) at a final concentration of 1.0 ng/mL.

Coculture {#cas12871-sec-0004}
---------

For monoculture, MKN45‐Luc cells were plated in 12‐well plates at a density of 1 × 10^3^ cells per well with 2 mL MSCGM. For direct coculture, MSCs and MKN45‐Luc cells were plated in the same well of 12‐well plates at a density of 1 × 10^3^ cells per well for each cell type with 2 mL MSCGM. For indirect coculture, Transwells with 0.4‐μm pore membrane in 12‐well plates (Costar, Cambridge, MA, USA) were used to allow both types of cells to share media without making any direct contact. Unless otherwise indicated, MSCs (1 × 10^3^ cells) were seeded in the upper chamber with 500 μL MSCGM, and MKN45‐Luc cells (1 × 10^3^ cells) were seeded in the lower chamber with 1500 μL MSCGM. To neutralize CXCL16, anti‐human CXCL16 antibody (R&D Systems, Minneapolis, MN, USA) or control IgG (R&D Systems) was added to the media at a concentration of 0.25 μg/mL.

Conditioned media {#cas12871-sec-0005}
-----------------

Mesenchymal stem cells untreated or treated with the respective siRNAs were plated at 1 × 10^4^ cells/mL in MSCGM and cultured for 6 days. The cell supernatants were collected as the conditioned media. To culture MKN45‐Luc cells with the conditioned media, cells were plated at 1 × 10^3^ cells/mL in the well of 12‐well plates with 25% (v/v) of conditioned medium and 75% (v/v) of MSCGM.

Luciferase assay {#cas12871-sec-0006}
----------------

Cells were lysed in Glo Lysis buffer (Promega, Madison, WI, USA). Aliquots of cell lysates were mixed with ONE Glo Luciferase Assay buffer (Promega), and the luciferase activities were measured by using the GloMax 96 microplate luminometer (Promega).

Enzyme‐linked immunosorbent assay {#cas12871-sec-0007}
---------------------------------

The culture supernatants from MSCs treated with si‐*Ror2* or si‐*CXCL16* siRNAs were collected. The CXCL16 concentration in the culture supernatants was determined using Quantikine ELISA kit (R&D Systems), according to the manufacturer\'s instructions.

Flow cytometric analysis {#cas12871-sec-0008}
------------------------

MKN45‐Luc cells treated with si‐*CXCR6* for 5 days were collected and fixed with 10% (v/v) formalin in PBS. Then cells were washed with PBS and incubated with mouse anti‐human CXCR6 antibody (R&D Systems) at a final concentration of 25 μg/mL, followed by incubation with Alexa488‐conjugated anti‐mouse IgG (Life Technologies, Carlsbad, CA, USA). Flow cytometric analysis was performed using the BD FACSVerse (Becton Dickinson, Franklin Lakes, NJ, USA).

Human chemokine array {#cas12871-sec-0009}
---------------------

Conditioned media obtained from *Ror2*‐silenced MSCs were analyzed using the Proteome Profiler Human Chemokine Array Kit (ARY017; R&D Systems), according to the manufacturer\'s instructions. Briefly, array membranes, spotted with capture antibodies to specific target proteins, were incubated overnight at 4°C with the conditioned media pretreated with a cocktail of biotinylated detection antibodies. Then, membranes were washed and incubated with streptavidin--HRP for 30 min at room temperature. After washing the membranes, captured proteins on the membranes were visualized using chemiluminescent detection reagents. Supplementary materials and methods are described in Data S1.

Results {#cas12871-sec-0010}
=======

Promoted proliferation of MKN45 cells by direct and indirect coculture with MSCs {#cas12871-sec-0011}
--------------------------------------------------------------------------------

We first examined a possible role of human bone marrow‐derived MSCs on the proliferation of an undifferentiated gastric cancer cell line, MKN45 cells which express Wnt5a at marginal levels, if any.[16](#cas12871-bib-0016){ref-type="ref"} To this end, we used MKN45‐Luc cells, which express luciferase stably, to monitor proliferation of MKN45(‐Luc) cells. When MKN45‐Luc cells were cultured singly for 12 h at different densities, both total viable cell numbers and luciferase activities increased in proportion to increased cell densities (Fig. S1), indicating that measurement of luciferase activities can be a reliable readout of proliferation of MKN45‐Luc cells.

When MKN45‐Luc cells were either cultured singly (MSCs−) or cocultured directly with MSCs (MSCs+), proliferation of MKN45‐Luc cells was promoted remarkably at day 9 after coculture with MSCs (Fig. [1](#cas12871-fig-0001){ref-type="fig"}a). We next examined whether the effect of coculture with MSCs on promoted proliferation of MKN45‐Luc cells would be mediated by direct cell--cell interaction or by a soluble mediator(s) produced by MSCs. Thus, we carried out indirect cocultures of MKN45‐Luc cells and MSCs by using Transwells that prohibit any direct contact between cells in the lower and upper chambers. As shown in Figure [1](#cas12871-fig-0001){ref-type="fig"}(b,c), indirect coculture of MKN45‐Luc cells with MSCs promoted proliferation of MKN45‐Luc cells significantly at day 9 after coculture with MSCs, indicating that a soluble mediator(s) produced by MSCs might play a role in promoting proliferation of MKN45 cells.

![Coculture with mesenchymal stem cells (MSCs) promotes proliferation of MKN45‐Luc cells. (a) MKN45‐Luc cells were either cultured singly (MSCs−) or directly with MSCs (MSCs+). (b,c) MKN45‐Luc cells were either cultured singly (MSCs−) or indirectly with MSCs (MSCs+) in Transwell chambers in which MKN45‐Luc and MSCs were seeded in the lower and upper chambers, respectively (b) or in the upper and lower chambers, respectively (c). Luciferase activities were measured at the indicated time points. Data are expressed as mean ± SD (*n* = 3). \**P* \< 0.005; \*\**P* \< 0.001, *t*‐test.](CAS-107-290-g001){#cas12871-fig-0001}

Role of Wnt5a‐Ror2 signaling in MSCs in promoting proliferation of MKN45 cells {#cas12871-sec-0012}
------------------------------------------------------------------------------

It was found that expression levels of both *Ror2* and *Wnt5a* were relatively high in MSCs, but were marginal if any in MKN45‐Luc cells (Fig. S2). Thus, we then examined a possible role of Wnt5a‐Ror2 signaling in MSCs in promoting proliferation of MKN45‐Luc cells. Suppressed expression of *Ror2* or *Wnt5a* in MSCs resulted in the inhibition of promoted proliferation of MKN45‐Luc cells by direct or indirect coculture with MSCs (Figs [2](#cas12871-fig-0002){ref-type="fig"},S3). Furthermore, proliferation and viability of MSCs were unaffected by suppressed expression of *Ror2* in the cells as assessed by WST assay (Fig. S4a). These results suggest that Wnt5a‐Ror2 signaling in MSCs might play a role in promoting proliferation of MKN45 cells.

![Expression of *Ror2* in mesenchymal stem cells (MSCs) is required for the ability of MSCs to promote proliferation of MKN45‐Luc cells in coculture. (a) Suppressed expression of *Ror2* in MSCs treated with siRNAs for *Ror2*. Cells were transfected with either control (*ctrl*) siRNA or three different siRNAs against *Ror2* (\#1, \#2, \#3) and cultured for 5 or 9 days. Expression levels of *Ror2* mRNA were measured by quantitative RT‐PCR analyses. (b,c) MKN45‐Luc cells were cultured singly (monoculture) or cocultured with siRNA‐transfected MSCs either directly (b) or indirectly (c). After 9 days in culture, luciferase activities were measured. Data are expressed as mean ± SD (*n* = 3). \**P* \< 0.005; \*\**P* \< 0.001, *t*‐test.](CAS-107-290-g002){#cas12871-fig-0002}

Induced expression of CXCL16 by Wnt5a‐Ror2 signaling in MSCs {#cas12871-sec-0013}
------------------------------------------------------------

To assess further the findings that MSCs produce a soluble mediator(s) that promotes proliferation of MKN45 cells, we first tested the effect of conditioned media from MSCs on proliferation of MKN45‐Luc cells. As expected, conditioned media from MSCs promoted proliferation of MKN45‐Luc cells (Fig. [3](#cas12871-fig-0003){ref-type="fig"}a). Interestingly, suppressed expression of *Ror2* in MSCs inhibited the effect of MSC‐conditioned media to promote proliferation of MKN45‐Luc cells (Fig. [3](#cas12871-fig-0003){ref-type="fig"}b), indicating that Wnt5a‐Ror2 signaling in MSCs might play a role in producing a soluble mediator(s) that promotes proliferation of MKN45 cells.

![Conditioned media from mesenchymal stem cells (MSCs) promote proliferation of MKN45‐Luc cells in a manner dependent on Ror2 expression in MSCs. (a) Conditioned media from MSCs promotes proliferation of MKN45‐Luc cells. MKN45‐Luc cells were cultured in the presence or absence of MSC‐conditioned media. Luciferase activities were measured at the indicated time points. Data are expressed as mean ± SD (*n* = 3). \**P* \< 0.05; \*\**P* \< 0.001, *t*‐test. (b) MKN45‐Luc cells were cultured in the presence of conditioned media from MSCs pretreated with either ctrl siRNA or three different siRNAs against *Ror2* (\#1, \#2, \#3). After 9 days in culture, luciferase activities were measured. Data are expressed as mean ± SD (*n* = 3). \**P* \< 0.05; \*\**P* \< 0.001, *t*‐test. (c) MSCs were transfected with either ctrl or *Ror2* (\#2) siRNA. After 6 days in culture, conditioned media were collected and subjected to chemokine array analysis. Boxed spots (B4) indicate protein levels of CXCL16, which decreased significantly and reproducibly following suppressed expression of *Ror2*. Other spots with different intensities between si‐Ctrl and si‐*Ror2* groups include C4 (interleukin \[IL\]‐8), C9 (CCL2), and E6 (CXCL12). A1, A10, and G1 represent reference spots. (d) Expression of *CXCL16* is downregulated by suppressed expression of *Ror2* in MSCs. Mesenchymal stem cells were transfected with either ctrl or *Ror2* siRNAs. After 6 days in culture, mRNA levels of *CXCL16* (left panel) and *Ror2* (right panel) were measured by quantitative RT‐PCR analyses. (e) MSCs were transfected with either ctrl or *Ror2* (\#1) siRNA. After 6 days in culture, conditioned media were collected to measure relative amounts of CXCL16 protein by ELISA. Data are expressed as mean ± SD (*n* = 3). \**P* \< 0.05, *t*‐test.](CAS-107-290-g003){#cas12871-fig-0003}

To identify a candidate soluble mediator(s) produced by MSCs through Wnt5a‐Ror2 signaling, we carried out a human chemokine array analysis using conditioned media from either MSCs treated with control (ctrl) siRNA or siRNAs against *Ror2*. As a result, among several candidate chemokines identified, CXCL16 was the most prominent one whose expression was inhibited significantly and reproducibly by suppressed expression of *Ror2* (Fig. [3](#cas12871-fig-0003){ref-type="fig"}c). In fact, expression of *CXCL16* was inhibited by suppressed expression of *Ror2* in MSCs as assessed by quantitative RT‐PCR (Fig. [3](#cas12871-fig-0003){ref-type="fig"}d). As CXCL16 can exist as a transmembrane protein and a soluble protein by cleavage with the ADAM family of proteases,[17](#cas12871-bib-0017){ref-type="ref"}, [18](#cas12871-bib-0018){ref-type="ref"}, [19](#cas12871-bib-0019){ref-type="ref"}, [20](#cas12871-bib-0020){ref-type="ref"}, [21](#cas12871-bib-0021){ref-type="ref"} we measured amounts of soluble CXCL16 secreted from MSCs following treatment with either ctrl siRNA or siRNAs against *Ror2* by ELISA. As shown in Figure [3](#cas12871-fig-0003){ref-type="fig"}(e), secretion of soluble CXCL16 from MSCs was inhibited significantly by suppressed expression of *Ror2*. In addition, expression of *CXCL16* was inhibited by suppressed expression of *Wnt5a* (Fig. S4b). These results indicate that Wnt5a‐Ror2 signaling in MSCs plays an important role in promoting expression and secretion of CXCL16.

Critical role of soluble CXCL16 in promoting proliferation of MKN45 cells {#cas12871-sec-0014}
-------------------------------------------------------------------------

We next examined the effect of soluble recombinant CXCL16 (rCXCL16) on proliferation of MKN45 cells. Importantly, proliferation of MKN45‐Luc cells was promoted by the addition of rCXCL16 after day 7 (Fig. [4](#cas12871-fig-0004){ref-type="fig"}a). To further assess the role of soluble CXCL16 secreted from MSCs in the promotion of MKN45 cell proliferation, MKN45‐Luc cells were cocultured directly or indirectly with MSCs pretreated with either ctrl siRNA or siRNA against *CXCL16*. As shown in Figure [4](#cas12871-fig-0004){ref-type="fig"}(b,c), expression of *CXCL16* mRNA and secretion of soluble CXCL16 were inhibited drastically by pretreatment of MSCs with siRNA against *CXCL16* and subsequent culture for 6 days. Interestingly, suppressed expression of CXCL16 in MSCs resulted in the inhibition of promoted proliferation of MKN45‐Luc cells by direct or indirect coculture with MSCs (Fig. [4](#cas12871-fig-0004){ref-type="fig"}d,e), indicating that soluble CXCL16, expressed in and secreted from MSCs through Wnt5a‐Ror2 signaling, plays an important role in promoting proliferation of MKN45 cells. To confirm further the role of soluble CXCL16 from MSCs in promoting proliferation of MKN45 cells, we examined the effect of a neutralizing antibody against CXCL16 on proliferation of MKN45‐Luc cells cocultured directly or indirectly with MSCs. As expected, promoted proliferation of MKN45‐Luc cells by direct or indirect coculture with MSCs was inhibited significantly by an addition of the neutralizing anti‐CXCL16 antibody (Fig. [4](#cas12871-fig-0004){ref-type="fig"}f,g), confirming the critical role of soluble CXCL16 in promoting proliferation of MKN45.

![Expression of CXCL16 in mesenchymal stem cells (MSCs) is required for the ability of MSCs to promote proliferation of MKN45‐Luc cells in coculture. (a) Recombinant CXCL16 (rCXCL16) promotes proliferation of MKN45‐Luc cells. MKN45‐Luc cells were cultured in the absence (vehicle) or presence of 1 ng/mL rCXCL16, and luciferase activities were measured at the indicated time points. Data are expressed as mean ± SD (*n* = 3). \*\**P* \< 0.001, *t*‐test. (b,c) Suppressed expression of CXCL16 in MSCs. MSCs were transfected with either ctrl or *CXCL16* siRNA. After 6 days in culture, mRNA levels of *CXCL16* were measured by quantitative RT‐PCR analyses (b). Conditioned media from the siRNA‐treated MSCs were collected to measure relative amounts of CXCL16 protein by ELISA (c). (d,e) MKN45‐Luc cells were cultured singly or cocultured with siRNA‐treated MSCs either directly (d) or indirectly (e). Luciferase activities were measured at the indicated time points. Data are expressed as mean ± SD (*n* = 3). \*\**P* \< 0.001, *t*‐test. (f,g) Effect of neutralizing antibody against CXCL16 on proliferation of MKN45‐Luc cells cocultured with MSCs. MKN45‐Luc cells were cocultured with MSCs either directly (f) or indirectly (g) in the presence of anti‐CXCL16 neutralizing antibody or control IgG. Luciferase activities were measured at the indicated time points. Data are expressed as mean ± SD (*n* = 3). \*\**P* \< 0.001, *t*‐test.](CAS-107-290-g004){#cas12871-fig-0004}

Critical role of CXCL16--CXCR6 signaling in promoted proliferation of MKN45 cells {#cas12871-sec-0015}
---------------------------------------------------------------------------------

It has been shown that CXCR6 acts as a receptor for soluble and transmembranous forms of CXCL16.[18](#cas12871-bib-0018){ref-type="ref"}, [19](#cas12871-bib-0019){ref-type="ref"}, [22](#cas12871-bib-0022){ref-type="ref"} Therefore, it can be envisaged that CXCR6 might be expressed on MKN45 cells to mediate CXCL16‐induced proliferation signaling. In fact, quantitative RT‐PCR analysis revealed remarkably high levels of *CXCR6* mRNA in MKN45‐Luc cells compared with those in MSCs (Fig. S5). Treatment of MKN45‐Luc cells with siRNA against *CXCR6* inhibited expression of *CXCR6* (Fig. [5](#cas12871-fig-0005){ref-type="fig"}a). Flow cytometric analysis also showed expression of cell surface CXCR6 proteins on MKN45‐Luc cells and its inhibition by the siRNA treatment (Fig. [5](#cas12871-fig-0005){ref-type="fig"}b). It was found that suppressed expression of *CXCR6* in MKN45‐Luc cells by itself had marginal effect, if any, on proliferation of MKN45‐Luc cells (monoculture) (Fig. S6). However, suppressed expression of *CXCR6* in MKN45‐Luc cells significantly inhibited the promotion of MKN45‐Luc cell proliferation by direct or indirect coculture with MSCs (Figs [5](#cas12871-fig-0005){ref-type="fig"}c,d,S6), indicating that CXCR6 expressed on MKN45 cells plays a critical role in the promotion of MKN45 cell proliferation by CXCL16 secreted from MSCs.

![Expression of CXCR6 in MKN45‐Luc cells is required for the ability of mesenchymal stem cells (MSCs) to promote proliferation of MKN45‐Luc cells in coculture. (a,b) Suppressed expression of *CXCR6* in MKN45‐Luc cells. MKN45‐Luc cells were transfected with either *ctrl* or *CXCR6* siRNA. After 6 days in culture, mRNA levels of *CXCR6* were measured by quantitative RT‐PCR analyses (a). Cell surface expression of CXCR6 protein was measured by flow cytometry (b). (c,d) MKN45‐Luc cells transfected with either ctrl or *CXCR6* siRNA were cocultured with MSCs either directly (c) or indirectly (d). Untreated MKN45‐Luc cells were also cultured singly (monoculture). Luciferase activities were measured at the indicated time points. Data are expressed as mean ± SD (*n* = 3). \**P* \< 0.005; \*\**P* \< 0.001 between si‐Ctrl and *si‐CXCR6* groups, *t*‐test.](CAS-107-290-g005){#cas12871-fig-0005}

Discussion {#cas12871-sec-0016}
==========

Growing evidence indicates the important roles of Wnt5a‐Ror2 signaling in the progression of various types of cancer cells.[4](#cas12871-bib-0004){ref-type="ref"}, [5](#cas12871-bib-0005){ref-type="ref"}, [6](#cas12871-bib-0006){ref-type="ref"}, [7](#cas12871-bib-0007){ref-type="ref"}, [8](#cas12871-bib-0008){ref-type="ref"} Here we show that Wnt5a‐Ror2 signaling plays an important role in bone marrow‐derived MSCs to produce soluble CXCL16, which in turn, acting on CXCR6, a receptor for CXCL16 expressed on MKN45 undifferentiated gastric cancer cells, to mediate the promotion of its proliferation. To our knowledge, this is for the first time the role of Wnt5a‐Ror2 signaling has been revealed by an external cue, in this case MSCs, to promote cancer cell progression.

In this study we used undifferentiated MKN45 gastric cancer cells to exclude the possibility of cancer cells proliferating in a cell‐autonomous manner through Wnt5a‐Ror2 signaling. MKN45 cells express both *Wnt5a* and *Ror2* marginally, if at all, whereas MSCs express them at relatively high levels (Fig. S2). Although the extent of the luciferase activities detected was varied under different experimental settings, proliferation of MKN45‐Luc cells was promoted remarkably at day 9 after direct or indirect coculture with MSCs through Wnt5a‐Ror2 signaling (Figs [1](#cas12871-fig-0001){ref-type="fig"}, [2](#cas12871-fig-0002){ref-type="fig"},S3). We further showed that CXCL16, expressed in and secreted from MSCs by Wnt5a‐Ror2 signaling, acts on CXCR6 expressed on MKN45‐Luc cells, thereby promoting proliferation of MKN45 cells (Figs [3](#cas12871-fig-0003){ref-type="fig"}, [4](#cas12871-fig-0004){ref-type="fig"}, [5](#cas12871-fig-0005){ref-type="fig"},S4b). In this respect, it should be noted that the CXCL16--CXCR6 axis has been shown to play an important role in promoting progression of prostate cancer cells by activating the AKT--mTOR pathways.[23](#cas12871-bib-0023){ref-type="ref"}, [24](#cas12871-bib-0024){ref-type="ref"}, [25](#cas12871-bib-0025){ref-type="ref"}, [26](#cas12871-bib-0026){ref-type="ref"}

As shown, the promoted effects of coculture with MSCs, and the addition of conditioned media from MSCs and rCXCL16 on proliferation of MKN45 cells can be detected only after day 7 or day 9 in culture (Figs [1](#cas12871-fig-0001){ref-type="fig"}, [2](#cas12871-fig-0002){ref-type="fig"}, [3](#cas12871-fig-0003){ref-type="fig"}, [4](#cas12871-fig-0004){ref-type="fig"}, [5](#cas12871-fig-0005){ref-type="fig"},S3). It is conceivable that the CXCL16--CXCR6 axis might activate further signaling to promote the eventual proliferation of MKN45 cells. Further study will be required to clarify this issue. It has also been reported that *in vitro* culture of MSCs alone or with cancer‐derived medium can induce its conversion into CAFs.[11](#cas12871-bib-0011){ref-type="ref"}, [27](#cas12871-bib-0027){ref-type="ref"} Although expression levels of *Ror2* and *Wnt5a* increased and decreased, respectively, during *in vitro* culture of MSCs alone (Fig. S2c), suppressed expression of either *Ror2* or *Wnt5a* failed to affect expression patterns and levels of CAF marker genes, including *α‐SMA*,*SDF‐1*, and *FAP* (data not shown), suggesting that Wnt5a‐Ror2 signaling in MSCs might not affect its conversion into CAFs and *vice versa*.

Collectively, our present findings reveal that soluble CXCL16, produced by MSCs through Wnt5a‐Ror2 signaling, can promote proliferation of MKN45 cells expressing CXCR6. Thus, it can be assumed that CXCL16, produced by MSCs, might also contribute to the promoted proliferation of other cancer cells that express CXCR6. Therefore, Wnt5a‐Ror2 signaling in MSCs and/or the CXCL16--CXCR6 axis between MSCs and cancer cells might be effective therapeutic targets to prevent cancer progression. Future study with *in vivo* xenograft analyses will be required to test this possibility.
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**Fig. S1.** Cell densities in culture do not affect proliferation rates of MKN45‐Luc cells.

**Fig. S2.** Expression levels of *Ror2* and *Wnt5a* in MKN45‐Luc cells and mesenchymal stem cells.

**Fig. S3.** Expression of *Wnt5a* in mesenchymal stem cells is required for the ability of mesenchymal stem cells to promote proliferation of MKN45‐Luc cells in culture.

**Fig. S4.** Effect of suppressed expression of *Ror2* or *Wnt5a* on viability of mesenchymal stem cells and expression of *CXCL16* in mesenchymal stem cells, respectively.

**Fig. S5.** Expression levels of *CXCR6* in MKN45‐Luc cells and mesenchymal stem cells.

**Fig. S6.** Effects of suppressed expression of *CXCR6* on proliferation of MKN45‐Luc cells cultured singly or cocultured with mesenchymal stem cells.
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Click here for additional data file.
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**Data S1.** Supplementary materials and methods.
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Click here for additional data file.
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